Start for free
Start for free
BS

Bear Stearns Health Innoventures L.P

North America, New York, United States, New York

Description

Bear Stearns Health Innoventures Management, L.L.C. is a venture capital firm specializing in early and mid stage investments.

Investor Profile

Bear Stearns Health Innoventures L.P has made 10 investments, with 0 in the past 12 months and 90% as lead.

Stage Focus

  • Series C (60%)
  • Series D (30%)
  • Series B (10%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Therapeutics
  • Biopharma
  • Genetics
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Bear Stearns Health Innoventures L.P frequently co-invest with?

Duke University
Duke University
North America, North Carolina, United States, Durham
Co-Investments: 2
Sprout Group
Sprout Group
North America, New York, United States, New York
Co-Investments: 4
HealthCare Ventures
HealthCare Ventures
North America, Massachusetts, United States, Cambridge
Co-Investments: 3
MPM Capital
MPM Capital
North America, Massachusetts, United States, Boston
Co-Investments: 4
Skyline Ventures
Skyline Ventures
North America, California, United States, Palo Alto
Co-Investments: 2
NV
NIF Ventures
North America, California, United States, Palo Alto
Co-Investments: 2
Rho Ventures
Rho Ventures
North America, New York, United States, New York
Co-Investments: 2
Genentech
Genentech
North America, California, United States, South San Francisco
Co-Investments: 2
Yasuda Enterprise Development
Yasuda Enterprise Development
Asia, Tokyo, Japan, Tokyo
Co-Investments: 2
Vertex Management
Vertex Management
Asia, Central Region, Singapore, Singapore
Co-Investments: 2

What are some of recent deals done by Bear Stearns Health Innoventures L.P?

Tolerx

Cambridge, Massachusetts, United States

Tolerx develops novel therapies that modulate T-cell activities to treat patients with autoimmune diseases, diabetes and cancer.

BiotechnologyHealth CareMedical
Series DOct 21, 2006
Amount Raised: $61,000,000
Affymax

Cupertino, California, United States

Affymax is a biopharmaceutical company.

BiopharmaBiotechnologyHealth Care
Series DJul 18, 2005
Amount Raised: $60,000,000
Tolerx

Cambridge, Massachusetts, United States

Tolerx develops novel therapies that modulate T-cell activities to treat patients with autoimmune diseases, diabetes and cancer.

BiotechnologyHealth CareMedical
Series DMar 29, 2005
Amount Raised: $31,000,000
PharmAthene

Annapolis, Maryland, United States

PharmAthene develops medical countermeasures to prevent and treat morbidity and mortality associated with biological and chemical weapons.

BiotechnologyHealth CareMedical
Series BOct 12, 2004
Amount Raised: $50,000,000
AGY Therapeutics

San Francisco, California, United States

A South San Francisco, Calif .-based biopharmaceutical company

BiopharmaBiotechnologyGeneticsMedicalTherapeutics
Series CAug 7, 2004
Amount Raised: $9,000,000
Affymax

Cupertino, California, United States

Affymax is a biopharmaceutical company.

BiopharmaBiotechnologyHealth Care
Series CApr 14, 2004
Amount Raised: $20,000,000
Corus Pharma

Seattle, Washington, United States

Corus Pharma Inc., a Seatle-based biotech and specialty drug company focused on respiratory and infectious diseases.

BiotechnologyHealth CarePharmaceutical
Series CApr 13, 2004
Amount Raised: $65,000,000
Raven Biotechnologies

South San Francisco, California, United States

Raven biotechnologies is focused on the development of monoclonal antibody therapeutics for the treatment of cancer.

BiotechnologyMedicalTherapeutics
Series CJan 3, 2003
Amount Raised: $40,000,000
Anesiva

South San Francisco, California, United States

Anesiva, Inc., a biopharmaceutical company, engages in the development and commercialization of novel therapeutic treatments for pain

BiotechnologyGeneticsHealth CareMedicalTherapeutics
Series CJul 23, 2002
Amount Raised: $50,374,000
Entelos

San Mateo, California, United States

Entelos is a provider of predictive biosimulation for drug discovery and development.

BiotechnologyHealth CareTherapeutics
Series CSep 6, 2001
Amount Raised: $25,000,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator